Stroke, Vol 17, 748-752, Copyright © 1986 by American Heart Association
A Fujisawa, M Matsumoto, T Matsuyama, H Ueda, A Wanaka, S Yoneda, K Kimura and T Kamada
The gerbil model was used to assess the therapeutic effects of the calcium
antagonist nimodipine on cerebral ischemia. Transient cerebral ischemia was
produced in each gerbil by bilateral common carotid occlusion of 10-, 15-
or 20-min duration. Nimodipine (0.01 or 0.1 mg/kg) was administered
intraperitoneally just before the carotid occlusion or 10-30 min after the
removal of the arterial clips. Morbidity of each animal was evaluated using
the stroke index, and the sum of stroke indices was calculated for
evaluating the overall morbidity during a particular period of reperfusion.
Mortality was observed for 24 hours after clip removal. Although, depending
on the timing of the drug administration, the low-dose (0.01 mg/kg)
nimodipine worsened the morbidity in the gerbils with 10-min ischemia, the
high- dose (0.1 mg/kg) of the drug had a clear beneficial effect on the
mortality associated with cerebral ischemia. These results are considered
worthwhile for further trials to assess the usefulness of nimodipine as a
therapeutic agent in the management of the acute ischemic stroke.
ARTICLES
The effect of the calcium antagonist nimodipine on the gerbil model of experimental cerebral ischemia
This article has been cited by other articles:
![]() |
L. B. Goldstein Pharmacologic Modulation of Recovery After Stroke: Clinical Data Neurorehabil Neural Repair, January 1, 1991; 5(1-2): 129 - 140. [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1986 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |